These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 17085054)
1. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides. Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antitumor activity of new quinoxaline derivatives. Corona P; Carta A; Loriga M; Vitale G; Paglietti G Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives. Zarranz B; Jaso A; Aldana I; Monge A Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857 [TBL] [Abstract][Full Text] [Related]
5. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma. Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent. Noolvi MN; Patel HM; Bhardwaj V; Chauhan A Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives. Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel anticancer compounds based on a quinoxalinehydrazine pharmacophore. Deng J; Taheri L; Grande F; Aiello F; Garofalo A; Neamati N ChemMedChem; 2008 Nov; 3(11):1677-86. PubMed ID: 18985651 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines. Onnis V; Cocco MT; Fadda R; Congiu C Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483 [TBL] [Abstract][Full Text] [Related]
10. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides. Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives. Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818 [TBL] [Abstract][Full Text] [Related]
12. [Design and synthesis of quinoxaline derivatives and their antitumor activities]. Zhao CH; Chen Y; Ding J; Duan WH Yao Xue Xue Bao; 2005 Sep; 40(9):814-9. PubMed ID: 16342683 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione. El-Hawash SA; Wahab AE Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives. Moorthy NS; Karthikeyan C; Trivedi P J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012 [TBL] [Abstract][Full Text] [Related]
15. Combination effects of SC144 and cytotoxic anticancer agents. Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes. Bollini M; Casal JJ; Bruno AM Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786 [TBL] [Abstract][Full Text] [Related]
17. Semisynthesis and in vitro anticancer activities of andrographolide analogues. Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents. Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities. El-Hawash SA; Habib NS; Kassem MA Arch Pharm (Weinheim); 2006 Oct; 339(10):564-71. PubMed ID: 17009301 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Moarbess G; Deleuze-Masquefa C; Bonnard V; Gayraud-Paniagua S; Vidal JR; Bressolle F; Pinguet F; Bonnet PA Bioorg Med Chem; 2008 Jul; 16(13):6601-10. PubMed ID: 18513976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]